Cart
sales@molnova.com
Arofylline
CAS No. 136145-07-8
Arofylline( LAS 31025 )
Catalog No. M28919 CAS No. 136145-07-8
Arofylline is a PDE4 inhibitor and can be used for asthma studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 409 | In Stock |
|
| 5MG | 415 | In Stock |
|
| 10MG | 614 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameArofylline
-
NoteResearch use only, not for human use.
-
Brief DescriptionArofylline is a PDE4 inhibitor and can be used for asthma studies.
-
DescriptionArofylline is a PDE4 inhibitor and can be used for asthma studies.
-
In Vitro——
-
In Vivo——
-
SynonymsLAS 31025
-
PathwayAngiogenesis
-
TargetPDE
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136145-07-8
-
Formula Weight304.73
-
Molecular FormulaC14H13ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCn1c(=O)n(-c2ccc(Cl)cc2)c2nc[nH]c2c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lin YL, Wu CF, Huang YT. Phenols from the roots of Rheum palmatum attenuate chemotaxis in rat hepatic stellate cells. Planta Med. 2008 Aug;74(10):1246-52.
molnova catalog
related products
-
Dypyridamole
Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.
-
Mopidamol
Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
-
Mirodenafil
Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.
